SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000930413-18-001993
Filing Date
2018-06-11
Accepted
2018-06-11 17:24:46
Documents
62
Period of Report
2018-04-30

Document Format Files

Seq Description Document Type Size
1 c91227_10q.htm 10-Q 562331
2 c91227_ex31-1.htm EX-31.1 8975
3 c91227_ex31-2.htm EX-31.2 8967
4 c91227_ex32-1.htm EX-32.1 3099
5 c91227_ex32-2.htm EX-32.2 3041
  Complete submission text file 0000930413-18-001993.txt   3605378

Data Files

Seq Description Document Type Size
6 enz-20180430.xml EX-101.INS 769193
7 enz-20180430.xsd EX-101.SCH 47086
8 enz-20180430_cal.xml EX-101.CAL 33276
9 enz-20180430_def.xml EX-101.DEF 204640
10 enz-20180430_lab.xml EX-101.LAB 314795
11 enz-20180430_pre.xml EX-101.PRE 212216
Mailing Address ENZO BIOCHEM INC 60 EXECUTIVE BLVD FARMINGDALE NY 11735
Business Address 60 EXECUTIVE BLVD FARMINGDALE NY 11735 5167555500
ENZO BIOCHEM INC (Filer) CIK: 0000316253 (see all company filings)

IRS No.: 132866202 | State of Incorp.: NY | Fiscal Year End: 0731
Type: 10-Q | Act: 34 | File No.: 001-09974 | Film No.: 18892866
SIC: 8071 Services-Medical Laboratories
Assistant Director 9